Sector Chart Imugene Limited

Equities

Delayed Australian S.E. Other stock markets 08:15:09 2024-05-20 pm EDT			5-day change	1st Jan Change
0.0685 ^AUD	-0.72%		-2.82%	-37.27%

Apr. 16	Imugene Signs Deal to Sell Manufacturing Facility For $6 Million	MT
Apr. 16	Kincell Bio, LLC signed an asset purchase agreement to acquire North Carolina manufacturing facility from Imugene Limited for $6 million.	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes